CLASS II Drug recall · Reported 27 Nov 2024 · FDA Enforcement Report
Bevacizumab (Avastin)1.25mg/, Sterile Injection Single-Dose Syringe recalled
Tailstorm Health is recalling Bevacizumab (Avastin)1.25mg/, Sterile Injection Single-Dose Syringe, distributed nationwide in the US. The recall was initiated on 6 Nov 2024 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0051-2025
- FDA event ID
- 95718
- Recalling firm
- Tailstorm Health, Phoenix, AZ
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 6 Nov 2024
- FDA classified
- 18 Nov 2024
- Reported
- 27 Nov 2024
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 6 Nov 2024 | Recall initiated by company | |
| 18 Nov 2024 | Classified by FDA | +12 days |
| 27 Nov 2024 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Sterility Assurance
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
Where it was distributed
Nationwide Within U.S.
Questions about this recall
Why was it recalled?
Lack of Sterility Assurance
Which lots are affected?
Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.
Where was it sold?
Nationwide Within U.S.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Tailstorm Health
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | LIDOcaine HCL Sterile Injection, USP, 20 mg/mL recalled | Tailstorm Health | Sterility | Nationwide |
| Drug | CLASS II | LIDOcaine HCl Injection, USP, 10mg/mL recalled by Tailstorm Health | Tailstorm Health | Sterility | Nationwide |
| Drug | CLASS II | BUPIVAcaine HCL Sterile injection recalled by Tailstorm Health | Tailstorm Health | Sterility | Nationwide |
| Drug | CLASS II | KETAmine Hydrochloride Injection, USP, 500mg/, (10mg/mL) recalled | Tailstorm Health | Sterility | Nationwide |
| Drug | CLASS II | LIDOcaine HCL Sterile Injection, USP, 100mg/, 1%, (10mg/mL) recalled | Tailstorm Health | Sterility | Nationwide |
Other Bevacizumab (avastin recalls
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | bevacizumab (Avastin) Injection, 1.25mg/ Fill) recalled | Fagron Compounding Services | Sterility | Nationwide |
| Drug | CLASS II | Bevacizumab (Avastin) 2.5mg/ PF Inj recalled by Leiter's Pharmacy | Leiter's Pharmacy | Sterility | Nationwide |